| EEF1B2 |
EEF1B2, EEF1B, EF1B: Elongation factor 1-beta |
EEF1G |
EEF1G, EF1G, PRO1608: Elongation factor 1-gamma |
5.69E3 |
Evidence |
O
|
| NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
5.62E3 |
Evidence |
O
|
| CRYAA |
CRYAA, CRYA1, HSPB4: Alpha-crystallin A chain |
CRYAB |
CRYAB, CRYA2: Alpha-crystallin B chain |
5.53E3 |
Evidence |
O
|
| FOS |
FOS, G0S7: Proto-oncogene protein c-fos |
JUNB |
JUNB: Transcription factor jun-B |
5.36E3 |
Evidence |
O
|
| COPE |
COPE: Coatomer subunit epsilon |
COPA |
COPA: Coatomer subunit alpha |
5.15E3 |
Evidence |
O
|
| ACTR3 |
ACTR3, ARP3: Actin-related protein 3 |
ACTG1 |
ACTR2, ARP2: Actin-related protein 2 |
5.05E3 |
Evidence |
O
|
| RBBP4 |
RBBP4, RBAP48: Histone-binding protein RBBP4 |
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
5.00E3 |
Evidence |
O
|
| FIGF |
FIGF, VEGFD: Vascular endothelial growth factor D precursor |
KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
4.86E3 |
Evidence |
O
|
| PSMC3 |
PSMC3, TBP1: 26S protease regulatory subunit 6A |
PSMC2 |
PSMC2, MSS1: 26S protease regulatory subunit 7 |
4.52E3 |
Evidence |
O
|
| ORC2L |
ORC2L, ORC2: Origin recognition complex subunit 2 |
CDC6 |
CDC6, CDC18L: Cell division control protein 6 homolog |
4.51E3 |
Evidence |
O
|
| SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
SMAD1 |
SMAD1, BSP1, MADH1, MADR1: Mothers against decapentaplegic homolog 1 |
4.29E3 |
Evidence |
O
|
| EIF2S2 |
EIF2S2, EIF2B: Eukaryotic translation initiation factor 2 subunit 2 |
EIF2S3 |
EIF2S3, EIF2G: Eukaryotic translation initiation factor 2 subunit 3 |
4.00E3 |
Evidence |
O
|
| TGFBR1 |
TGFBR1: TGF-beta receptor type-1 precursor |
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
3.79E3 |
Evidence |
O
|
| COPA |
COPA: Coatomer subunit alpha |
LSM4 |
LSM4: U6 snRNA-associated Sm-like protein LSm4 |
3.64E3 |
Evidence |
O
|
| SKI |
SKI: Ski oncogene |
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
3.52E3 |
Evidence |
O
|
| WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
CRKL |
CRKL: Crk-like protein |
3.35E3 |
Evidence |
O
|
| CDK2 |
CDK2: Cell division protein kinase 2 |
MCM3 |
MCM3: DNA replication licensing factor MCM3 |
3.27E3 |
Evidence |
O
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
3.26E3 |
Evidence |
O
|
| PRKAG1 |
PRKAG1: 5'-AMP-activated protein kinase subunit gamma-1 |
PRKAB1 |
PRKAB1, AMPK: 5'-AMP-activated protein kinase subunit beta-1 |
3.16E3 |
Evidence |
O
|
| COPB2 |
COPB2: Coatomer subunit beta' |
COPA |
COPA: Coatomer subunit alpha |
2.87E3 |
Evidence |
O
|
| RANBP1 |
RANBP1: Ran-specific GTPase-activating protein |
TNPO1 |
|
2.69E3 |
Evidence |
O
|
| EXOSC4 |
EXOSC4, RRP41, SKI6: Exosome complex exonuclease RRP41 |
EXOSC5 |
EXOSC5, CML28, RRP46: Exosome complex exonuclease RRP46 |
2.69E3 |
Evidence |
O
|
| FOS |
FOS, G0S7: Proto-oncogene protein c-fos |
JUN |
JUN: Transcription factor AP-1 |
2.51E3 |
Evidence |
O
|
| LSM8 |
LSM8: U6 snRNA-associated Sm-like protein LSm8 |
LSM3 |
LSM3, MDS017: U6 snRNA-associated Sm-like protein LSm3 |
2.37E3 |
Evidence |
O
|
| TBP |
TBP, GTF2D1, TF2D, TFIID: TATA-box-binding protein |
GTF2A2 |
GTF2A2, TF2A2: Transcription initiation factor IIA gamma chain |
2.35E3 |
Evidence |
O
|
